These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24789589)

  • 1. Heart failure in African Americans: disparities can be overcome.
    Sharma A; Colvin-Adams M; Yancy CW
    Cleve Clin J Med; 2014 May; 81(5):301-11. PubMed ID: 24789589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
    Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
    Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
    Raj L; Adhyaru B
    Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
    Echols MR; Yancy CW
    Vasc Health Risk Manag; 2006; 2(4):423-31. PubMed ID: 17323596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con position.
    Ferdinand KC; Serrano CC; Ferdinand DP
    Curr Hypertens Rep; 2002 Aug; 4(4):311-8. PubMed ID: 12117459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart Failure.
    Wu A
    Ann Intern Med; 2018 Jun; 168(11):ITC81-ITC96. PubMed ID: 29868816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
    Lim WY; Woldman S
    Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based treatment of chronic heart failure.
    Rosen D; Decaro MV; Graham MG
    Compr Ther; 2007; 33(1):2-17. PubMed ID: 17984487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
    Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
    Ziaeian B; Fonarow GC; Heidenreich PA
    JACC Heart Fail; 2017 Sep; 5(9):632-639. PubMed ID: 28711446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive therapy and management of the transition of care in patients with heart failure.
    Feitell S; Hankins SR; Eisen HJ
    Cardiol Clin; 2014 Feb; 32(1):163-74, x. PubMed ID: 24286587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
    Colvin-Adams M; Taylor AL
    Cleve Clin J Med; 2007 Mar; 74(3):227-34. PubMed ID: 17375804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
    Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
    J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in heart failure therapeutics.
    Ishizawar D; Yancy C
    Heart Fail Clin; 2010 Jan; 6(1):65-74. PubMed ID: 19945062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BiDil: primary care physicians first and cardiologist when?
    Matthews GE
    J Natl Med Assoc; 2007 Jun; 99(6):697-9; quiz 700. PubMed ID: 17595944
    [No Abstract]   [Full Text] [Related]  

  • 17. Race-based therapeutics.
    Bloche MG
    N Engl J Med; 2004 Nov; 351(20):2035-7. PubMed ID: 15533852
    [No Abstract]   [Full Text] [Related]  

  • 18. Dilemmas With Race and Heart Failure Treatment.
    Butler J; Konstam MA
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27707751
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic heart failure: how can the family doctor put current guidelines into practice?].
    Finsterer S; Weyerbrock S; Basler M; Mühling H; Silber S
    MMW Fortschr Med; 2008 Mar; 150(12):29-33. PubMed ID: 18533593
    [No Abstract]   [Full Text] [Related]  

  • 20. Food & Drug Administration panel approves heart failure medication aimed at African-Americans.
    Pharmacogenomics; 2005 Jul; 6(5):455. PubMed ID: 16705760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.